Loading...
01/11 03:35
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance, with EPS and net income growth, increased book value, and a dividend hike. The Palisades acquisition and investment in technology suggest positive future growth. Despite some concerns about interest expense and market volatility, the company's strategic measures, like hedging interest rate risk and managing liquidity, are reassuring. The Q&A indicates analysts' cautious optimism, with no major negative trends disclosed. Considering the company's small-cap status, the positive financial indicators and strategic initiatives suggest a likely positive stock price movement over the next two weeks.
Earnings Per Share (EPS) $0.41, up from $0.38 year-over-year.
GAAP Net Income $145.9 million, representing a year-over-year increase, specific change not mentioned.
Book Value $21.17 per share, increased by 7.4% year-over-year.
Earnings Available for Distribution (EAD) $33.5 million, or $0.41 per share, year-over-year change not specified.
Economic Net Interest Income $72.3 million, year-over-year change not specified.
Yield on Average Interest Earning Assets 5.9%, year-over-year change not specified.
Average Cost of Funds 4.4%, year-over-year change not specified.
Net Interest Spread 1.5%, year-over-year change not specified.
Total Leverage 3.9 to 1, year-over-year change not specified.
Recourse Leverage 1.2 to 1, year-over-year change not specified.
Total Cash and Unencumbered Assets $697 million, year-over-year change not specified.
Economic Return on GAAP Book Value 9.2%, year-over-year change not specified.
Economic Net Interest Income Return on Average Equity 11.2%, year-over-year change not specified.
GAAP Return on Average Equity 25.9%, year-over-year change not specified.
EAD Return on Average Equity 8.1%, year-over-year change not specified.
Transactional Expenses $5.7 million, reflecting increased securitization activity.
Cash Extracted from Refinancings More than $100 million, due to refinancing of key non-mark to market facilities.
Cash from Securitizations $187 million, unlocked through refinancing of loans.
Palisades Acquisition: Chimera completed its first full quarter of acquiring Palisades, integrating it seamlessly into its platform, enhancing capabilities and diversifying revenue.
Securitization of Non-QM Loans: In January, Chimera acquired and securitized $288 million in non-QM loans, expecting low teen returns.
Agency Specified Pools: In March, Chimera picked up $149 million of agency specified pools, anticipating mid-teen levered returns.
Third-Party Loans Under Management: Third-party loans under management by Palisades Advisory Services increased by 43% year-over-year, reaching nearly $24 billion.
Total Assets Managed: Chimera's total assets, including on-balance sheet and managed assets, reached nearly $37 billion.
Cash Extraction from Refinancing: Chimera extracted over $100 million in cash from refinancing two key non-mark to market facilities.
Securitization Execution Risk Mitigation: Chimera closed a short position in 2-year Treasury future contracts to protect the net interest spread of CIM 2025-I1.
Diversification Strategy: Chimera aims to diversify its portfolio, grow recurring fee income, and add liquidity while seeking accretive platforms.
Resilience and Flexibility: Chimera is building a hybrid mortgage REIT that is resilient and diversified, focusing on disciplined risk management.
Market Volatility: Interest rate volatility spiked in February and March, leading to wider credit spreads and uncertainty in the market.
Economic Factors: Forecasts have shifted to reflect lower growth expectations and increased inflation risk for the balance of the year.
Housing Market Challenges: Existing home sales declined to a 4 million unit annualized pace, marking the slowest first quarter since 2009, and single-family housing starts were down 14% from the prior quarter.
Securitization Execution Risk: The company is mitigating securitization execution risk by shorting 2-year Treasury future contracts.
Funding Shocks: The company has positioned its portfolio to withstand potential funding shocks and spread widening.
Interest Rate Risk: The company entered into a $1 billion 2-year interest rate cap to protect against future interest rate movements.
Increased Interest Expense: The additional debt from refinancing will increase annual run rate interest expense by approximately $11 million.
Liquidity Management: Despite market dislocation, the resilience of the liability structure limited margin calls to less than $20 million.
Acquisition of Palisades: Chimera has successfully integrated Palisades into its platform, enhancing capabilities and diversifying revenue streams.
Third-party loans under management: Increased by 43% year-over-year, reaching nearly $24 billion.
Balance sheet moves: Exercised call rights on non-Remic securitizations, unlocking $187 million for reinvestment.
Securitization activity: Acquired and securitized $288 million in non-QM loans and settled $100 million in residential transition loans.
Liquidity and cash management: Refinanced key non-mark to market facilities, extracting over $100 million in additional cash.
Portfolio diversification: Plans to grow recurring fee income and add liquidity while seeking accretive platforms.
Book value outlook: Current book value is estimated to be flat to slightly down from the end of Q1 2025.
Economic return expectations: Expecting mid-teen levered returns on new investments.
Capital deployment strategy: Cautious approach to capital deployment due to ongoing macroeconomic uncertainty.
Breakeven return-on-capital: Approximately 5.8%, with any return above this expected to be accretive to earnings.
Dividend per share: $0.37 for the first quarter of 2025.
Cash unlocked from refinancing: $187 million from refinancing non-Remic securitizations.
Annual run rate interest expense increase: Approximately $11 million due to additional debt.
Breakeven return-on-capital: Approximately 5.8%.
The earnings call reveals mixed signals: a 62% YoY increase in share price and positive product growth, but a net loss and restructuring efforts raise concerns. The Q&A highlights uncertainties with regulatory approvals and contract renewals, while SG&A expenses are expected to rise. The market cap suggests a moderate reaction, balancing positive growth with operational and financial uncertainties.
The earnings call reveals several concerns: increased transaction expenses, interest rate sensitivity, portfolio repositioning dragging earnings, and a rise in loan delinquencies. While there are positive elements like dividend growth expectations and increased liquidity, the overall sentiment is weighed down by negative financial performance, including a GAAP net loss, negative economic return, and unclear management responses in the Q&A. The market cap suggests a moderate reaction, but the negative aspects are likely to dominate, predicting a stock price decline in the range of -2% to -8%.
The earnings call reveals mixed signals: strong growth in third-party loans and strategic acquisitions are positive, but the lack of specific year-over-year changes and a decline in book value are concerning. The Q&A section shows management's optimism about future earnings and strategic diversification, but also highlights uncertainties in dividend strategy and market conditions. The market cap suggests moderate sensitivity to these factors. Overall, the sentiment leans towards neutral, with potential positive catalysts offset by financial and strategic uncertainties.
The earnings call highlights strong financial performance, with EPS and net income growth, increased book value, and a dividend hike. The Palisades acquisition and investment in technology suggest positive future growth. Despite some concerns about interest expense and market volatility, the company's strategic measures, like hedging interest rate risk and managing liquidity, are reassuring. The Q&A indicates analysts' cautious optimism, with no major negative trends disclosed. Considering the company's small-cap status, the positive financial indicators and strategic initiatives suggest a likely positive stock price movement over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
